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Defining Ocular Perfusion Pressure
Dr Liebmann: Ocular perfusion pressure can be thought of as the pressure at which blood enters the eye. Mathematically, OPP is defined as the arterial BP minus IOP. Both of these determinants are dynamic biological parameters. Intraocular pressure varies throughout the day and from day to day. Blood pressure is even more variable, with significant changes throughout each cardiac cycle. During each heartbeat, systemic BP rises to a peak, the systolic BP, and then drops to a trough, the diastolic BP. Thus, OPP is also a dynamic parameter, varying as both BP and IOP vary.
Just as the complex variability of BP can be described using summary parameters-systolic, diastolic, and mean BP-the same summary parameters can be applied to OPP. Mean OPP (MPP) is the difference between mean arterial BP and IOP. Mean arterial BP is calculated using a formula (Table 1) that accounts for diastole taking up most of the cardiac cycle. Systolic OPP (SPP) and diastolic OPP (DPP) are calculated as systolic (or diastolic) BP minus IOP (Table 1) .
Clearly, OPP changes with changes in BP, IOP, or both. When BP is high and/or IOP is low, OPP is high; likewise, when BP is low and/or IOP is high, OPP is low. Because BP is significantly greater than IOP, OPP is more sensitive to changes in BP than to changes in IOP. Blood pressure in the normal range varies on the order of 40 to 60 mm Hg within each cardiac cycle, while typical circadian variations in IOP are generally on the order of 5 to 8 mm Hg. Therefore, patients with significantly elevated BP (systemic hypertension) or those with significant dips in BP at night (nocturnal hypotension) may experience dramatic changes in OPP throughout the day.
Dr Weinreb: Mathematically, diastolic BP has a greater effect than systolic BP in calculating mean OPP.
Dr Greenfield: The formula for calculating mean OPP reveals that a 10-mm Hg change in systolic BP results in a 2.2-mm Hg change in mean OPP, while a similar 10-mm Hg change in diastolic BP produces a 4.4-mm Hg change in mean OPP.
Dr Weinreb: Likewise, the systolic and diastolic BPs have greater effect than the IOP in determining OPP. A 10-mm Hg change in either systolic or diastolic BP is likely a very common event in most people. A 10-mm Hg change in IOP, however, is likely a fairly uncommon event for most people with or without primary open-angle glaucoma (POAG). Reduced OPP is emerging as a significant risk factor for glaucoma. Dr Varma reviews the data supporting this association.
Ocular Perfusion Pressure and Glaucoma: The Evidence
Dr Varma: Five major epidemiologic studies have provided data on the relationship between BP, OPP, IOP, and glaucoma. Four of these studies (Baltimore Eye Survey, Egna-Neumarkt Study, Proyecto VER, Los Angeles Latino Eye Study) were crosssectional studies, 1-4 while the fifth (Barbados Eye Study) was a prospective, longitudinal study. 5 Key design features and findings of these studies are summarized in Table 2 .
The Baltimore Eye Survey was a cross-sectional study of persons of European and African ancestry in Baltimore, Maryland. The relevant finding from this study was that lower OPP was strongly associated with a higher prevalence of POAG. In fact, patients in the lowest category of DPP (<30 mm Hg) had a 6-fold higher risk for having glaucoma compared with those whose DPP was >50 mm Hg. 1 Glaucoma is among the most common causes of irreversible vision loss worldwide. While its primary etiology remains incompletely understood, we have developed a robust understanding of the risk factors that contribute to the development and progression of the disease. Among these, intraocular pressure (IOP) remains the most important risk factor, both because of its strength of association with the disease and because it remains the only modifiable risk factor. In addition to IOP, vascular factors have long been suspected of playing a role in the glaucomatous process. Evidence from epidemiologic studies and clinical trials alike suggests that ocular perfusion pressure (OPP)-in simplest terms, the difference between IOP and systemic blood pressure (BP)-as well as other factors such as BP, vasospasm, and ischemia may all contribute to glaucoma risk. A panel of glaucoma specialists with clinical and academic expertise in the vascular aspects of glaucoma herein present a conceptual framework for the role of OPP in glaucoma, review the evidence to support this association, and provide guidance for assessing and incorporating OPP into the evaluation and management of glaucoma patients in the office.
Ocular perfusion pressure can be thought of as the pressure at which blood enters the eye. The Los Angeles Latino Eye Study was a cross-sectional study of Latinos/Hispanics residing in Los Angeles, California. Compared with people whose DPP was between 51 and 60 mm Hg, those whose DPP was below 40 mm Hg had a 1.9-fold higher risk for glaucoma. 4 In fact, low DPP, SPP, and MPP were all highly associated with the risk for glaucoma in this study (Figure 1) .
-Jeffrey Liebmann, MD
In contrast to these 4 studies, the Barbados Eye Study was a prospective, longitudinal study of predominantly Afro-Caribbeans on the island of Barbados in the eastern Caribbean Ocean. Participants were enrolled in a cross-sectional prevalence study similar to the ones described above, but were reexamined 4 and 9 years after enrollment. This study design provides insight into the risk for developing glaucoma, in contrast to cross-sectional studies that describe preexisting glaucoma. At 4 years, low MPP, SPP, and DPP were all associated with a higher risk (2.6-to 3.2-fold) for developing new glaucoma. 5 At 9 years, all 3 perfusion pressures remained significantly associated with developing glaucoma. 6
Dr Ritch: Blood pressure is highly variable. How was it characterized in the studies?
Dr Varma:
In most of these studies, BP was measured at least twice at baseline in a sitting position, so the analyses did not rely on a single snapshot value.
Dr Liebmann:
The theme throughout is that low OPP is a significant risk factor for glaucoma. The absolute numbers were a bit different in these studies, but the message is the same: Low DPP is a risk factor for glaucoma. Do these studies reveal a risk associated with elevated OPP?
Dr Varma:
The risk for glaucoma decreases as OPP increases, and it plateaus at the higher levels.
Dr Greenfield: Ocular perfusion pressure may be reduced in 2 clinical scenarios: when BP is low or when IOP is high. In these epidemiologic studies, do we know if OPP was reduced because of low BP or because of high IOP? This is an important point because if elevated IOP was the reason for the low OPP, then BP may be less relevant and the increased glaucoma risk could be attributable primarily to elevated IOP.
In most of these studies, mean IOP was in the 'normal' range. Interestingly, in these studies and in other epidemiologic studies, half or more of the newly diagnosed open-angle glaucoma cases have IOP in the normal range. We often think of glaucoma as being a high-pressure disease. This is more myth than fact. The average untreated IOP of Hispanics newly diagnosed with glaucoma in the Los Angeles Latino Eye Study was 17 mm Hg, with only 18% of all eyes with glaucoma having an IOP greater than 21 mm Hg. 7 The median IOP of all glaucomatous eyes in non-Hispanic Whites and African Americans in the Baltimore Eye Survey was 20 mm Hg, with 41% of all eyes having an IOP greater than 21 mm Hg. 8 So we cannot entirely attribute IOPs greater than 21 mm Hg for this increased risk for glaucoma. The low BP is relevant.
Dr Weinreb: I find it fascinating and important that in the Barbados study, OPP was a much more powerful risk factor for glaucoma than was IOP. I wish we had information about nocturnal IOP and BP from these epidemiologic studies. At night, IOP goes up and BP-particularly diastolic BP-goes 4 Low DPP is a risk factor for glaucoma.
-Jeffrey Liebmann, MD
We often think of glaucoma as being a high-pressure disease. This is more myth than fact. The Role of Ocular Perfusion Pressure in Glaucoma down, so the DPP is dually affected. I wonder if nocturnal DPP is even more strongly associated with glaucoma risk than are daytime values.
Dr Gupta:
Our concept of glaucoma is shifting from a disease of a single pressure-IOP-to a disease of multiple pressures. Ocular perfusion pressure is clearly an important factor in glaucoma. Other research points to a potential role for intracranial pressure (ICP). Glaucoma is more than just IOP.
Dr Weinreb: Dr Gupta has spent many years investigating the role of the cerebrovascular system in glaucoma. She provides us with an overview of her work.
The Cerebrovascular System in Glaucoma
Dr Gupta: We tend to think of glaucoma as a primary eye disease. As such, ophthalmologists have sole responsibility for its management, and all treatment options are directed at the eye. A substantial body of research stretches this view, and considers glaucoma disease in the context of central nervous system degeneration. In fact, most of the neurovisual system resides within the white matter of the brain. Glaucoma is much more than a disease of the eye, with evidence that it is a neurodegenerative disorder of the central visual system. There is demonstrable atrophy of the lateral geniculate nucleus-the terminus for optic nerve axons-in glaucoma ( Figure 2 ). 9, 10 This has been demonstrated in primates 11 as well as in humans, 10 the latter both by magnetic resonance imaging (MRI) in vivo and in histological specimens taken postmortem.
Further, blood vessels of the lateral geniculate nucleus demonstrate oxidative damage when stained appropriately. 12 More posteriorly, the visual cortex also manifests damage in glaucoma compared with controls in both primate 13 and human studies. 9 Functional deficits can be demonstrated in humans with glaucoma by functional MRI, which reveals reduced levels of blood oxygen in areas of the visual cortex that correspond to known visual field defects. 14 According to what we know about the vascular contributions to the central visual system, much of it lies in a watershed zone of the brain. Watershed zones are more vulnerable to hypoperfusion and ischemia. It is possible that under conditions of unstable perfusion, such as low BP, the visual system becomes even more susceptible to neural degeneration.
When the vascular supply to the brain is considered (Figure 3 ), the role of cerebrovascular factors in glaucoma are better appreciated. The branches of the carotid artery-anterior, middle, and posterior cerebral arteries-supply most of the front aspect of the brain and, via the ophthalmic artery, the eyes.
The vertebrobasilar system supplies the rear aspect of the brain. These 2 circulations are connected through the circle of Willis. Between these 2 circulations is a segment of brain that is supplied by minor branches of these major vessels-and within this so-called watershed zone lie the optic tracts, the lateral geniculate nuclei, the optic radiations, and the visual cortex.
An anatomic configuration of the vascular circulations of the brain provides insight into the importance of OPP. When BP is low, these watershed zones are quite vulnerable to hypoperfusion and ischemia. It is possible that under conditions 5 I find it fascinating and important that in the Barbados study, OPP was a much more powerful risk factor for glaucoma than was IOP.
-Robert N. Weinreb, MD
Our concept of glaucoma is shifting from a disease of a single pressure-IOP-to a disease of multiple pressures.
-Neeru Gupta, MD, PhD, MBA Glaucoma is much more than a disease of the eye, with evidence that it is a neurodegenerative disorder of the 
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According to what we know about the vascular contributions to the central visual system, much of it lies in a watershed zone of the brain. Watershed zones are more vulnerable to hypoperfusion and ischemia. It is possible that under conditions of unstable perfusion, such as low BP, the visual system becomes even more susceptible to neural degeneration.
-Neeru Gupta, MD, PhD, MBA of unstable perfusion, ischemic insults to these tissues could contribute to the neurodegenerative changes seen throughout the visual system in glaucoma. 15
Dr Ritch: This watershed zone could be endangered by impairment of either the cerebral or the vertebrobasilar system. Is there a known role for vertebrobasilar insufficiency in glaucoma?
Dr Gupta: To my knowledge, this has not been reported. However, anything that compromises the BP within the cerebrovascular arterial system would affect both cerebral and ocular perfusion pressure. Visual structures in the watershed areas of the brain would be particularly more susceptible to global hypoperfusion.
Dr Weinreb: Hypoperfusion of the optic nerve may play a role in the development of glaucoma; it also is thought to be the basis of acute anterior ischemic optic neuropathy (AION). Could these 2 entities differ in terms of the vascular beds affected? For example, could AION be related to ischemia within the anterior circulation of the optic nerve and glaucoma to the more posterior vascular beds?
Dr Greenfield: I find it intriguing that while there are many well-established systemic disorders of chronic ischemia-such as congestive heart failure, ischemic heart disease, chronic ischemic dementia, and chronic ischemic renal disease-we have not characterized a chronic ischemic optic neuropathy. Perhaps that condition is glaucoma.
Dr Varma:
Tools under development-such as optical coherence tomographic (OCT) angiography-may be able to provide insight into these issues. This technology has the potential to noninvasively image at the level of the capillaries and may provide functional data on blood flow. With that information, perhaps we will then better understand the relative contributions of IOP and blood flow to glaucomatous optic nerve damage. Dr Greenfield: In an ideal world, yes, we would, because OPP measurement is noninvasive, inexpensive, and easy to obtain, and provides clinicians with data to more fully assess not only patients' glaucoma risk, but also their overall systemic health. In a busy clinical practice, however, in which a clinician sees 40 to 50 patients per day, the added time necessary to obtain BP readings and to calculate and record OPP will cost money and reduce clinical efficiency, and will likely not be effective for treatment planning in most patients.
Dr Ritch: I agree. For instance, if I discovered a low OPP in a patient whose glaucoma has remained stable for many years, I might notify the internist of this finding, but I would be unlikely to change the patient's glaucoma management to try to further lower IOP by 1 or 3 mm Hg; but if the glaucoma was not stable, I would obtain 24-hour blood pressure measurements, which we do routinely, and consider salt loading if nocturnal OPP was reduced. There are many risk factors which make me consider glaucoma occurring at normal IOP to be a nocturnal disease.
Dr Weinreb: But, secondly, is it correct to assume that there are subsets of patients in whom knowledge of OPP might be beneficial?
6
OPP measurement is noninvasive, inexpensive, and easy to obtain, and provides clinicians with data to more fully assess not only patients' glaucoma risk, but also their overall systemic health.
-David S. Greenfield, MD
Dr Greenfield: You are correct in your assumption. Measurement of OPP would be beneficial (Table 3) in POAG patients with IOP in the normal range. We can agree or disagree as to whether normal-tension glaucoma is a separate clinical entity or is merely POAG occurring within the normal range of IOP. But in 2 major clinical trials of patients with glaucoma and IOP in the normal range, vascular risk factors were found to be the strongest predictors of progression. The Collaborative Normal-Tension Glaucoma Study identified optic disc hemorrhage and migraine as predictive factors for progression, 16 and the Low-Pressure Glaucoma Treatment Study (LoGTS) identified reduced mean OPP and the use of systemic antihypertensive medication as risk factors for visual field progression. 17 Patients with optic disc hemorrhage might benefit from OPP assessment. Disc hemorrhages can occur in both normal-tension and high-tension glaucoma and the exact mechanism by which they appear remains elusive. In LoGTS, low mean OPP as well as low mean systolic BP, migraine headache, and use of systemic beta-blockers were all associated with the development of optic disc hemorrhage. 18 Patients whose glaucoma is progressing at what appears to be an adequately low IOP level also may benefit from OPP assessment. Charlson and colleagues conducted a study in which a reduction in mean arterial pressure from daytime to nighttime was found to be a significant predictor of visual field progression in such patients. 19 Finally, patients who report a history of low BP, who are using multiple systemic antihypertensive medications, or who have symptoms of orthostatic hypotension, may benefit from OPP assessment. Dr Greenfield: All valid options. A single BP and IOP measurement allows a quick snapshot, but because both BP and IOP vary widely, it will not be a complete characterization. This is the same challenge we face with IOP. If there is particular concern that low OPP may be contributing to glaucoma progression, a single-day diurnal assessment might be worthwhile, or a modified diurnal assessment can be constructed by seeing the patient at different times of the day on different visits. Certainly 24-hour ambulatory BP monitoring is the most robust approach and will reveal "nocturnal dippers" whose BP bottoms out at night, but such monitoring is both cumbersome and expensive, and we do not yet have satisfactory 24-hour IOP monitoring tools with which to characterize 24-hour OPP. 19 indirectly suggests that patients with glaucoma progression using systemic antihypertensive agents may benefit from adjusting the dose or time of antihypertensive administration to avoid low mean arterial pressure, particularly during the nocturnal period.
My colleagues and I recently published a paper showing that the visual field can improve in the short term following surgical IOP reduction, and that the magnitude of the visual field improvement is significantly associated with the mean OPP. 20 We prospectively compared a group of 30 eyes that had surgical IOP lowering via trabeculectomy or glaucoma drainage device implantation with a group of 41 control eyes that had stable IOP during the same time period. Following IOP reduction on average from 18 to 10 mm Hg, a significantly greater number of visual field points improved in the surgical group than in the control group. This improvement was not correlated with the change in IOP, but was significantly related to improvement in postoperative mean OPP. Our study is consistent with other reports of visual field improvement after IOP reduction 21, 22 and provides indirect support that OPP may be related to both visual field progression and visual field improvement.
Dr Weinreb:
On the basis of the foregoing discussion and in light of the data presented, is it reasonable to propose that OPP is potentially a new modifiable risk factor for glaucoma care?
Dr Greenfield: In cross-sectional and longitudinal studies, we have seen that OPP is an important risk factor for glaucoma 7 There are many risk factors which make me consider glaucoma occurring at normal IOP to be a nocturnal disease. onset and glaucoma progression. Therefore, OPP might be a potentially modifiable risk factor. We know that at present IOP is the only modifiable risk factor. Intraocular pressure and diastolic BP contribute more from a mathematical calculation to OPP than does systolic BP, and clinicians need to pay attention to the various factors that influence OPP. We should consider measuring OPP in selected patients, particularly those in whom glaucoma progression is occurring at low levels of IOP, and/or patients who develop optic disc hemorrhage.
If OPP is a modifiable risk factor, how might we modify it?
Dr Ritch: The first step is to review a patient's medical and medication history. Patients with systemic hypertension may be overmedicated, with their diastolic BP dropping lower than necessary. Most important, in my view, is the nocturnal diastolic pressure, which is lowered by the patient's taking of BP medications at bedtime. Just as IOP has a 24-hour fluctuation, so does BP, which may be high during the day but normal nocturnally, and taking BP medication in the evening can produce a significant drop in nocturnal mean arterial pressure. Being mindful of the nocturnal dip in diastolic BP, I would communicate with the internist or cardiologist and ask if treatment can be shifted from the evening to the morning to best protect against nocturnal dips. Topical beta-blockers may also lower BP at night in some patients 23 and measuring 24-hour BP with and without topical beta-blockers may provide useful information. If the patient is dependent on beta-blockers for IOP control, this must be taken into account.
Dr Varma:
Consider a patient who is not being overmedicated, or in whom the current antihypertensive regimen cannot be reduced. Is there any value to salt addition as a means of preventing diastolic BP from bottoming out during the night?
Dr Ritch: Although the evidence is limited, we have recommended salt loading to some patients in order to increase OPP. We initially start with salty snacks, such as pretzels and potato chips, then move to V8 juice, which has a high sodium content, or salt tablets. We have had patients whose nocturnal dipping did improve significantly. Granted, these examples are from individual case reports. There are no data from epidemiologic studies or trials to support salt loading in this setting.
Dr Gupta: I agree with you. We all have patients who are progressing at low IOP and who are nocturnal dippers. Twentyfour-hour BP monitoring may help to identify these patients. Salty snacks or beverages at night may help, although the evidence is anecdotal.
Case From the Files of Robert Ritch, MD
Salt loading may or may not be successful at elevating nocturnal BP. A case in point is a patient who was extremely difficult to control. This was a 50-year-old white woman with -7.00 diopters of myopia and recurrent disc hemorrhages with progression of her glaucoma with IOPs in the low to mid teens. She had lamina cribrosa defects on enhanced depth imaging-OCT, and polysomnography was negative for obstructive sleep apnea. Twenty-four-hour BP measurement showed extensive nocturnal dipping. A repeat measurement showed improvement, but recurrent disc hemorrhages prompted a third measurement, which showed regression and an apparent loss of continued effect of salt loading (Figures 4A, 4B, 4C ). She eventually underwent trabeculectomy OU. 8 We should consider measuring OPP in selected patients, particularly those in whom glaucoma progression is occurring at low levels of IOP, and/or patients who develop optic disc hemorrhage.
-David S. Greenfield, MD
Patients with systemic hypertension may be overmedicated, with their diastolic BP dropping lower than necessary. . . . Being mindful of the nocturnal dip in diastolic BP, I would communicate with the internist or cardiologist and ask if treatment can be shifted from the evening to the morning to best protect against nocturnal dips.
-Robert Ritch, MD This is in contrast to another patient who had significant improvement after salt loading with cessation of progression to date, although repeat testing has not since been performed ( Figures 5A, 5B ).
Summary and Conclusions
The concept of OPP as the balance of 2 opposing forces-BP and IOP-has been offered. The evidence linking OPP to glaucoma has been reviewed. A biologically plausible mechanism by which central nervous system hypoperfusion may predispose to glaucoma has been presented. Further, we have described the notion of OPP as a modifiable risk factor for glaucoma progression independent of IOP reduction. In summary, the panel has drawn up a series of points to consider regarding the role of OPP in glaucoma. 1. Please list one or more things, if any, you learned from participating in this educational activity that you did not already know. ____________________________ _________________________________________________________________________________________________________________________________ 2. As a result of the knowledge gained in this educational activity, how likely are you to implement changes in your practice? 4=definitely will implement changes 3=likely will implement changes 2=likely will not implement any changes 1=definitely will not make any changes 
